BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 16125114)

  • 1. Calpains in muscle wasting.
    Bartoli M; Richard I
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2115-33. PubMed ID: 16125114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-dependent proteolytic system and muscle dysfunctions: a possible role of calpains in sarcopenia.
    Dargelos E; Poussard S; Brulé C; Daury L; Cottin P
    Biochimie; 2008 Feb; 90(2):359-68. PubMed ID: 17881114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca(2+)-dependent proteolysis in muscle wasting.
    Costelli P; Reffo P; Penna F; Autelli R; Bonelli G; Baccino FM
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2134-46. PubMed ID: 15893952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca2+ activation of diffusible and bound pools of mu-calpain in rat skeletal muscle.
    Murphy RM; Verburg E; Lamb GD
    J Physiol; 2006 Oct; 576(Pt 2):595-612. PubMed ID: 16857710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limb-girdle muscular dystrophy type 2A can result from accelerated autoproteolytic inactivation of calpain 3.
    Garnham CP; Hanna RA; Chou JS; Low KE; Gourlay K; Campbell RL; Beckmann JS; Davies PL
    Biochemistry; 2009 Apr; 48(15):3457-67. PubMed ID: 19226146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpain-related diseases.
    Branca D
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1098-104. PubMed ID: 15336956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic study of calpain interacting proteins during skeletal muscle aging.
    Brulé C; Dargelos E; Diallo R; Listrat A; Béchet D; Cottin P; Poussard S
    Biochimie; 2010 Dec; 92(12):1923-33. PubMed ID: 20850499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome.
    Chrobáková T; Hermanová M; Kroupová I; Vondrácek P; Maríková T; Mazanec R; Zámecník J; Stanek J; Havlová M; Fajkusová L
    Neuromuscul Disord; 2004 Oct; 14(10):659-65. PubMed ID: 15351423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpains, skeletal muscle function and exercise.
    Murphy RM
    Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):385-91. PubMed ID: 19793101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in the research of the relationship between calpains and post-burn skeletal muscle wasting].
    Ma L; Chai JK
    Zhonghua Shao Shang Za Zhi; 2013 Jun; 29(3):304-7. PubMed ID: 24059960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpains and disease.
    Zatz M; Starling A
    N Engl J Med; 2005 Jun; 352(23):2413-23. PubMed ID: 15944426
    [No Abstract]   [Full Text] [Related]  

  • 12. Calpain 3: a key regulator of the sarcomere?
    Duguez S; Bartoli M; Richard I
    FEBS J; 2006 Aug; 273(15):3427-36. PubMed ID: 16884488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A.
    Groen EJ; Charlton R; Barresi R; Anderson LV; Eagle M; Hudson J; Koref MS; Straub V; Bushby KM
    Brain; 2007 Dec; 130(Pt 12):3237-49. PubMed ID: 18055493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain 3 Expression Pattern during Gastrocnemius Muscle Atrophy and Regeneration Following Sciatic Nerve Injury in Rats.
    Wu R; Yan Y; Yao J; Liu Y; Zhao J; Liu M
    Int J Mol Sci; 2015 Nov; 16(11):26927-35. PubMed ID: 26569227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limb girdle muscular dystrophy in a sibling pair with a homozygous Ser606Leu mutation in the alternatively spliced IS2 region of calpain 3.
    Jenne DE; Kley RA; Vorgerd M; Schröder JM; Weis J; Reimann H; Albrecht B; Nürnberg P; Thiele H; Müller CR; Meng G; Witt CC; Labeit S
    Biol Chem; 2005 Jan; 386(1):61-7. PubMed ID: 15843148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin-lacking mdx mice.
    Gailly P; De Backer F; Van Schoor M; Gillis JM
    J Physiol; 2007 Aug; 582(Pt 3):1261-75. PubMed ID: 17510188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myofibrillar protein turnover: the proteasome and the calpains.
    Goll DE; Neti G; Mares SW; Thompson VF
    J Anim Sci; 2008 Apr; 86(14 Suppl):E19-35. PubMed ID: 17709792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Force impairment in calpain 3-deficient mice is not correlated with mechanical disruption.
    Fougerousse F; Gonin P; Durand M; Richard I; Raymackers JM
    Muscle Nerve; 2003 May; 27(5):616-23. PubMed ID: 12707983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro.
    Kramerova I; Kudryashova E; Tidball JG; Spencer MJ
    Hum Mol Genet; 2004 Jul; 13(13):1373-88. PubMed ID: 15138196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A.
    Bartoli M; Roudaut C; Martin S; Fougerousse F; Suel L; Poupiot J; Gicquel E; Noulet F; Danos O; Richard I
    Mol Ther; 2006 Feb; 13(2):250-9. PubMed ID: 16290124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.